Trump and Kennedy's health industry deals are at risk of vanishing
The agreements, covering issues like drug pricing, reducing the use of synthetic food dyes, and cutting back on insurance prior authorization rules, were announced with fanfare and touted as victories.
In the closing weeks of his reelection campaign, Michigan Republican Rep. Tom Barrett collaborated with Health and Human Services Secretary Robert F. Kennedy Jr. on a sprawling apple orchard, farm, and winery. They discussed Trump administration initiatives aimed at enhancing the American diet, such as eliminating certain artificial food dyes.
Barrett stated in a June Instagram post, "We had a great discussion about healthy options for all Americans and taking back control of our healthcare." However, many of the administration's most prominent health efforts hinge on voluntary agreements, lacking the enforceability of traditional federal regulations. These deals, while popular among voters for their appeal across party lines and economic divides, have minimal oversight, making it difficult to track progress.
In some instances, the administration claims victories that have not yet been realized. Republicans praise the deal-making strategy, as it aligns with their anti-regulatory stance and allows the administration to quickly present accomplishments for President Trump and his allies. The lack of transparency in these deals raises concerns about their long-term impact, as there is little documentation or follow-through to substantiate the administration's health agenda.
Written by urgent.news from CBS News's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
